PARIS — Oral treatment with the novel fatty acid synthase inhibitor denifanstat was associated with significant improvements in moderate-to-severe acne in a phase 3 trial presented at the European ...
Treatment with a 1726-nm laser resulted in sustained efficacy for moderate-to-severe acne, with more than 90% of treated patients achieving at least a 50% reduction in inflammatory lesions at 52 weeks ...
Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback